CEACAM5 and pachyonychia congenita: While a number of biomarkers can be used in PC, i.e. Carbohydrate antigen 19-9 (CA 19-9) and Carcinoembryonic antigen (CEA), none are highly accurate in diagnosing PC or predicting treatment response13.